Status:
COMPLETED
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
Lead Sponsor:
AstraZeneca
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
Brief Summary
Replication of three clinical trial emulations CANVAS, LEADER, and SAVOR TIMI that form part of the RCT-Duplicate initiative, sponsored by the FDA and delivered by the Brigham and Women's Hospital and...
Detailed Description
RCT-duplicate (RCT-D) is an initiative led by the Brigham and Women's Hospital and Harvard Medical School, that selected 30 clinical trials as part of an empirical experiment where these trials would ...
Eligibility Criteria
Inclusion
- The Eligibility Criteria for CANVAS, LEADER and SAVOR-TIMI are replicated
- Please see the Criteria for each under:
- CANVAS: https://clinicaltrials.gov/ct2/show/NCT03936010
- LEADER: https://clinicaltrials.gov/ct2/show/NCT03936049
- SAVOR-TIMI: https://clinicaltrials.gov/ct2/show/NCT03936023
Exclusion
Key Trial Info
Start Date :
May 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
239990 Patients enrolled
Trial Details
Trial ID
NCT06099067
Start Date
May 15 2020
End Date
August 31 2023
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Gothenburg, Sweden, 43183